| 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis … R Aggarwal, LG Rider, N Ruperto, N Bayat, B Erman, BM Feldman, ... Arthritis & Rheumatology 69 (5), 898-910, 2017 | 227 | 2017 |
| Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis M Filková, B Aradi, L Šenolt, C Ospelt, S Vettori, H Mann, A Filer, K Raza, ... Annals of the rheumatic diseases 73 (10), 1898-1904, 2014 | 222 | 2014 |
| Delays in assessment of patients with rheumatoid arthritis: variations across Europe K Raza, R Stack, K Kumar, A Filer, J Detert, H Bastian, GR Burmester, ... Annals of the rheumatic diseases 70 (10), 1822-1825, 2011 | 192 | 2011 |
| Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic … S Rothwell, RG Cooper, IE Lundberg, FW Miller, PK Gregersen, J Bowes, ... Annals of the rheumatic diseases 75 (8), 1558-1566, 2016 | 164 | 2016 |
| Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial A Tjärnlund, Q Tang, C Wick, M Dastmalchi, H Mann, JT Studýnková, ... Annals of the rheumatic diseases 77 (1), 55-62, 2018 | 130 | 2018 |
| Increased serum levels of B cell activating factor (BAFF) in subsets of patients with idiopathic inflammatory myopathies O Kryštůfková, T Vallerskog, SB Helmers, H Mann, I Půtová, J Běláček, ... Annals of the rheumatic diseases 68 (6), 836-843, 2009 | 123 | 2009 |
| Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA K Pavelka, S Forejtova, J Stolfa, K Chroust, L Buresova, H Mann, ... Clin Exp Rheumatol 27 (6), 958-963, 2009 | 104 | 2009 |
| Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis L Andrés Cerezo, H Mann, O Pecha, L Pleštilová, K Pavelka, J Vencovský, ... Arthritis research & therapy 13, 1-9, 2011 | 102 | 2011 |
| A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 … J Závada, M Uher, K Sisol, Š Forejtová, K Jarošová, H Mann, J Vencovský, ... Annals of the rheumatic diseases 75 (1), 96-102, 2016 | 83 | 2016 |
| Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis J Hurnakova, J Zavada, P Hanova, H Hulejova, M Klein, H Mann, ... Arthritis Research & Therapy 17, 1-6, 2015 | 82 | 2015 |
| Increasing incidence of immune-mediated necrotizing myopathy: single-centre experience M Klein, H Mann, L Pleštilová, J Zámečník, Z Betteridge, N McHugh, ... Rheumatology 54 (11), 2010-2014, 2015 | 77 | 2015 |
| Efficacy and safety of subcutaneous secukinumab 150 mg with or without loading regimen in psoriatic arthritis: results from the FUTURE 4 study AJ Kivitz, P Nash, H Tahir, A Everding, H Mann, A Kaszuba, P Pellet, ... Rheumatology and therapy 6, 393-407, 2019 | 67 | 2019 |
| MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis V Hruskova, R Jandova, L Vernerova, H Mann, O Pecha, K Prajzlerova, ... Arthritis research & therapy 18, 1-8, 2016 | 67 | 2016 |
| Increased serum concentration of immune cell derived microparticles in polymyositis/dermatomyositis Z Baka, L Senolt, J Vencovsky, H Mann, PS Simon, Á Kittel, E Buzás, ... Immunology Letters 128 (2), 124-130, 2010 | 63 | 2010 |
| Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis Y Kochi, Y Kamatani, Y Kondo, A Suzuki, E Kawakami, R Hiwa, ... Annals of the rheumatic diseases 77 (4), 602-611, 2018 | 62 | 2018 |
| Immune‐array analysis in sporadic inclusion body myositis reveals HLA–DRB1 amino acid heterogeneity across the myositis spectrum S Rothwell, RG Cooper, IE Lundberg, PK Gregersen, MG Hanna, ... Arthritis & Rheumatology 69 (5), 1090-1099, 2017 | 61 | 2017 |
| The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies L Andrés Cerezo, K Kuncová, H Mann, M Tomčík, J Zámečník, ... Rheumatology 50 (10), 1766-1772, 2011 | 45 | 2011 |
| Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in … LM Ørnbjerg, CH Brahe, J Askling, A Ciurea, H Mann, F Onen, ... Annals of the rheumatic diseases 78 (11), 1536-1544, 2019 | 44 | 2019 |
| Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein J Hurnakova, H Hulejova, J Zavada, M Komarc, LA Cerezo, H Mann, ... Clinical rheumatology 37, 2055-2062, 2018 | 44 | 2018 |
| Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic Š Forejtová, H Mann, J Štolfa, K Vedral, I Fenclová, D Némethová, ... Clinical rheumatology 27, 1005-1013, 2008 | 42 | 2008 |
